How long after keytruda should i watch for side effects?

How long after Keytruda should I watch for side effects?

Keytruda works by blocking the PD-1 receptor on immune cells, which removes a checkpoint that normally suppresses immune activity. This can lead to immune-related adverse events that appear at different times during and after treatment.

Immune-related side effects tied to Keytruda can begin as early as the first weeks of treatment. Many appear within the first 3 months, but delayed reactions can show up months or even years after stopping infusions. Patients often watch closely for 6–12 months post-treatment because some effects take time to develop.

Why do immune-related side effects appear so late after Keytruda?

The checkpoint blockade effect persists after drug levels drop. Immune cells remain activated even once Keytruda has mostly cleared from the body. This is why clinicians continue monitoring long after infusions end.

What side effects are patients asking about?

Common ones include fatigue, rash, diarrhea, and endocrine disorders such as hypothyroidism. Rarer but serious issues involve colitis, hepatitis, pneumonitis, nephritis, and skin reactions. Patients report these events in clinical reports and real-world data.

How does Keytruda's duration of effect compare with Opdivo?

Both drugs belong to the same PD-1 inhibitor class. They share similar half-lives and immune activation profiles. Side effect onset windows are comparable, but individual patient factors influence timing.

When does Keytruda's patent expire?

Keytruda is protected by multiple patents held by Merck. Early reports suggest core patents expire around 2028–2032. Biosimilar versions may arrive once those rights end.